| Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity S Kiesgen, JC Messinger, NK Chintala, Z Tano, PS Adusumilli Nature protocols 16 (3), 1331-1342, 2021 | 95 | 2021 |
| A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value K Biernacki, S Lopez-Guzman, JC Messinger, NV Banavar, J Rotrosen, ... Neuropsychopharmacology 47 (8), 1440-1448, 2022 | 20 | 2022 |
| Neither Ethical Nor Effective: The False Promise of Involuntary Commitment to Address the Overdose Crisis MS Sinha, JC Messinger, L Beletsky The Journal of Law, Medicine & Ethics 48 (4), 741-743, 2020 | 12 | 2020 |
| Moving Naloxone Over the Counter Is Necessary but Not Sufficient JC Messinger, L Beletsky, AS Kesselheim, RE Barenie Annals of Internal Medicine 176 (8), 1109-1112, 2023 | 11 | 2023 |
| Involuntary Commitment for Substance Use: Addiction Care Professionals Must Reject Enabling Coercion and Patient Harm J Messinger, L Beletsky Journal of Addiction Medicine 15 (4), 280-282, 2021 | 9 | 2021 |
| Civil commitment for opioid misuse: do short-term benefits outweigh long-term harms? JC Messinger, DJ Ikeda, A Sarpatwari Journal of medical ethics 48 (9), 608-610, 2022 | 7 | 2022 |
| Recognizing and Reducing the Impact of Trauma of Hospitalization: Considerations for Persons Who Use Drugs JC Messinger, J Suzuki Journal of Addiction Medicine 16 (1), 7-9, 2022 | 7 | 2022 |
| The Other Infodemic: Media Misinformation about Involuntary Commitment for Substance Use S Kang, K McCreedy, J Messinger, R Bhargava, L Beletsky Journal of addiction medicine 17 (6), e396-e398, 2023 | 3 | 2023 |
| The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report JC Messinger, E Hakimi, L Vercollone Journal of Addiction Medicine 17 (2), 230-232, 2023 | 3 | 2023 |
| Against our instincts: decriminalization of buprenorphine JC Messinger, A Chukka, JW Boyd The Journal of the American Board of Family Medicine 35 (2), 394-397, 2022 | 3 | 2022 |
| Outcomes for patients discharged to involuntary commitment for substance use disorder directly from the hospital JC Messinger, L Vercollone, SG Weiner, W Bromstedt, C Garner, J Garza, ... Community Mental Health Journal 59 (7), 1300-1305, 2023 | 2 | 2023 |
| Liver transplantation in alcohol-associated liver disease: ensuring equity through new processes JC Messinger, DW Hanto, MP Curry, K Ladin Liver Transplantation 29 (5), 539-547, 2023 | 2 | 2023 |
| Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid JC Messinger, AS Kesselheim, SM Vine, MA Fischer, RE Barenie Substance abuse: research and treatment 16, 11782218221126972, 2022 | 2 | 2022 |
| Advancing Harm Reduction Services in the United States: The Untapped Role of the Americans with Disabilities Act A Fletes, MKD Reyes, JC Messinger, V Blake, L Beletsky Yale J. Health Pol'y L. & Ethics 21, 61, 2022 | 2 | 2022 |
| Advancing Syringe Services in the United States: The Untapped Role of the Americans with Disabilities Act A Fletes, MK Delos Reyes, JC Messinger, V Blake, L Beletsky | | 2022 |
| Fluctuations in Craving and Mood State Bias Subjective Valuation in Addiction J Messinger, S Lopez-Guzman, N Banavar, J Rotrosen, P Glimcher, ... Biological Psychiatry 83 (9), S232-S233, 2018 | | 2018 |
| A Phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy BT Aftab, RR Shen, CD Pham, M Wu, DJ Munson, PS Adusumilli, ... | | |